* To identify the incidence of LIT among critically ill patients, as limited studies have only addressed this population. * To evaluate the impact of several factors on the incidence of LIT, the time to onset of LIT, and the time to recovery of platelets. * To study the effect of concurrent medications (enoxaparin, unfractinated heparin, piperacillin, carbapenems, tigecycline, fluconazole or voriconazole, digoxin, amiodarone, acetaminophen, tirofiban, statins, and antiepileptics) frequently used in critically ill patients on the incidence of LIT. * To investigate the impact of possible medications with an antioxidant effect on the prevention of LIT. * To assess the impact of LIT on composite end point (mortality, bleeding, and length of stay)
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Incidence of Linezolid-induced thrombocytopenia (LIT) thrombocytopenia
Timeframe: One year